Literature DB >> 30963630

Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.

Isel Castro1,2, Elmira Ekinci1, Xuemei Huang1, Hassan Ali Cheaito1, Young-Hoon Ahn3, Jesus Olivero-Verbel2, Q Ping Dou1.   

Abstract

The levels of organic pollutants, such as optical brightener (OB) compounds, in the global environment have been increasing in recent years. The toxicological effects and signal transduction systems associated with OB toxicity have not been thoroughly studied. The ubiquitin-proteasome system (UPS) plays a crucial role in regulating multiple essential cellular processes, and proteasome-associated cysteine deubiquitinases (DUBs), ubiquitin C-terminal hydrolase L5 (UCHL5) and USP14, are two major regulators for (de)ubiquitination and stability of many important target proteins. Therefore, potential inhibition of UCHL5 and USP14 activities by some environmental chemicals might cause in vivo toxicity. In the current study we hypothesize that electrophilic OB compounds, such as 4,4'-diamino-2,2'-stilbenedisulfonic acid(DAST), fluorescent brightener 28 (FB-28) and FB-71, can interact with the catalytic triads (CYS, HIS, and ASP) of UCHL5 and USP14 and inhibit their enzymatic activities, leading to cell growth suppression. This hypothesis is supported by our findings presented in this study. Results from in silico computational docking and ubiquitin vinyl sulfone assay confirmed the UCHL5/USP14-inhibitory activities of these OB compounds that have potencies in an order of: FB-71 > FB-28 > DAST. Furthermore, inhibition of these two proteasomal DUBs by OBs resulted in cell growth inhibition and apoptosis induction in two human breast cancer cell models. In addition, we found that OB-mediated DUB inhibition triggers a feedback reaction in which expression of UCHL5 and USP14 proteins is increased to compromise the suppressed activities. Our study suggests that these commonly used OB compounds may target and inhibit proteasomal cysteine DUBs, which should contribute to their toxicological effects in vivo.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  degradation; environmental pollutant; fluorescent brightening agent; molecular target; posttranslational modification

Year:  2019        PMID: 30963630      PMCID: PMC6570543          DOI: 10.1002/jcb.28682

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

1.  Structural characterization of human Uch37.

Authors:  Sethe E Burgie; Craig A Bingman; Ameet B Soni; George N Phillips
Journal:  Proteins       Date:  2011-09-26

2.  AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

Authors:  Oleg Trott; Arthur J Olson
Journal:  J Comput Chem       Date:  2010-01-30       Impact factor: 3.376

3.  Inhibition of proteasome deubiquitinating activity as a new cancer therapy.

Authors:  Pádraig D'Arcy; Slavica Brnjic; Maria Hägg Olofsson; Mårten Fryknäs; Kristina Lindsten; Michelandrea De Cesare; Paola Perego; Behnam Sadeghi; Moustapha Hassan; Rolf Larsson; Stig Linder
Journal:  Nat Med       Date:  2011-11-06       Impact factor: 53.440

4.  Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14.

Authors:  Min Hu; Pingwei Li; Ling Song; Philip D Jeffrey; Tatiana A Chenova; Keith D Wilkinson; Robert E Cohen; Yigong Shi
Journal:  EMBO J       Date:  2005-10-06       Impact factor: 11.598

5.  Biodegradability, toxicity and mutagenicity of detergents: Integrated experimental evaluations.

Authors:  Roberta Pedrazzani; Elisabetta Ceretti; Ilaria Zerbini; Rosario Casale; Eleonora Gozio; Giorgio Bertanza; Umberto Gelatti; Francesco Donato; Donatella Feretti
Journal:  Ecotoxicol Environ Saf       Date:  2012-08-14       Impact factor: 6.291

6.  Structural basis for the activation and inhibition of the UCH37 deubiquitylase.

Authors:  Ryan T Vander Linden; Casey W Hemmis; Benjamin Schmitt; Ada Ndoja; Frank G Whitby; Howard Robinson; Robert E Cohen; Tingting Yao; Christopher P Hill
Journal:  Mol Cell       Date:  2015-02-19       Impact factor: 17.970

Review 7.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

8.  Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain.

Authors:  Kazuya Nishio; Sang-Woo Kim; Kentaro Kawai; Tsunehiro Mizushima; Takashi Yamane; Jun Hamazaki; Shigeo Murata; Keiji Tanaka; Yukio Morimoto
Journal:  Biochem Biophys Res Commun       Date:  2009-10-20       Impact factor: 3.575

9.  Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design.

Authors:  David M Smith; Kenyon G Daniel; Zhigang Wang; Wayne C Guida; Tak-Hang Chan; Q Ping Dou
Journal:  Proteins       Date:  2004-01-01

10.  The proteasome is a molecular target of environmental toxic organotins.

Authors:  Guoqing Shi; Di Chen; Guangshu Zhai; Marina S Chen; Qiuzhi Cindy Cui; Qunfang Zhou; Bin He; Q Ping Dou; Guibin Jiang
Journal:  Environ Health Perspect       Date:  2008-10-23       Impact factor: 9.031

View more
  1 in total

1.  Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency.

Authors:  Yu-Shui Ma; Xiao-Feng Wang; Yun-Jie Zhang; Pei Luo; Hui-Deng Long; Liu Li; Hui-Qiong Yang; Ru-Ting Xie; Cheng-You Jia; Gai-Xia Lu; Zheng-Yan Chang; Jia-Jia Zhang; Shao-Bo Xue; Zhong-Wei Lv; Fei Yu; Qing Xia; Da Fu
Journal:  Mol Ther Oncolytics       Date:  2020-01-11       Impact factor: 7.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.